These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16299339)

  • 21. [Invasive aspergillosis in hematological patients].
    Rask CU; Peterslund NA
    Ugeskr Laeger; 2000 Feb; 162(6):773-7. PubMed ID: 10689950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enzyme-linked immunosorbent assay of serum IgG antibodies to Aspergillus fumigatus antigen using mouse monoclonal antibody to human IgG].
    Kobayashi M
    Arerugi; 1985 Mar; 34(3):162-72. PubMed ID: 3899058
    [No Abstract]   [Full Text] [Related]  

  • 23. Innate Lung Defense during Invasive Aspergillosis: New Mechanisms.
    Garth JM; Steele C
    J Innate Immun; 2017; 9(3):271-280. PubMed ID: 28231567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma.
    Schuh JM; Blease K; Brühl H; Mack M; Hogaboam CM
    Eur J Immunol; 2003 Nov; 33(11):3080-90. PubMed ID: 14579276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of anti-aspergillus IgG type antibody in the sera by solid phase immunoradiometric assay--comparison with gel precipitation test in cases of pulmonary aspergilloma].
    Danbara T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Aug; 21(8):745-52. PubMed ID: 6363780
    [No Abstract]   [Full Text] [Related]  

  • 26. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinate against aspergillosis! A call to arms of the immune system.
    Stevens DA
    Clin Infect Dis; 2004 Apr; 38(8):1131-6. PubMed ID: 15095219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis.
    Cenci E; Mencacci A; Casagrande A; Mosci P; Bistoni F; Romani L
    J Infect Dis; 2001 Sep; 184(5):610-7. PubMed ID: 11494166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of local immunity in invasive pulmonary aspergillosis].
    Aldebert D; Pinel C; Brion JP; Ambroise-Thomas P; Grillot R
    Presse Med; 2001 Sep 8-15; 30(25 Pt 1):1258-64. PubMed ID: 11603269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgE antibodies in bronchopulmonary aspergillosis.
    Pauwels R; Stevens EM; Van Der Straeten M
    Ann Allergy; 1976 Sep; 37(3):195-200. PubMed ID: 786083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis.
    Shao C; Qu J; He L; Zhang Y; Wang J; Zhou H; Wang Y; Liu X
    Genes Immun; 2005 Mar; 6(2):103-14. PubMed ID: 15674391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunomorphology of sensitization. XII. Immunomorphology of the lung during experimental aerogenic sensitization].
    Eskenasy A; Molan M; Alexandresco C
    Rev Roum Med; 1974; 12(4):285-91. PubMed ID: 4218659
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tools, progress and questions in the molecular study of Aspergillus fumigatus and invasive aspergillosis].
    Latgé JP; Paris S; Sarfati J; Debeaupuis JP; Diaquin M; Girardin H
    Pathol Biol (Paris); 1994 Sep; 42(7):632-9. PubMed ID: 7877854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus.
    Walsh TJ; Roilides E; Cortez K; Kottilil S; Bailey J; Lyman CA
    Med Mycol; 2005 May; 43 Suppl 1():S165-72. PubMed ID: 16114132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis.
    Mehrad B; Wiekowski M; Morrison BE; Chen SC; Coronel EC; Manfra DJ; Lira SA
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1263-8. PubMed ID: 12403697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host.
    Brown E; Freedman S; Arbeit R; Come S
    Am J Med; 1980 Oct; 69(4):624-7. PubMed ID: 7424951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differentially expressed genes in immunosuppressive and healthy mice after intranasal inoculation of Aspergillus fumigatus].
    Wang WL; Li RY; Zhu XJ; Wang DL
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):787-90. PubMed ID: 12899760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination.
    Bozza S; Clavaud C; Giovannini G; Fontaine T; Beauvais A; Sarfati J; D'Angelo C; Perruccio K; Bonifazi P; Zagarella S; Moretti S; Bistoni F; Latgé JP; Romani L
    J Immunol; 2009 Aug; 183(4):2407-14. PubMed ID: 19625642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive pulmonary aspergillosis in non-immunocompromised patients.
    Hovenden JL; Nicklason F; Barnes RA
    BMJ; 1991 Mar; 302(6776):583-4. PubMed ID: 2021725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.